Old Web
English
Sign In
Acemap
>
authorDetail
>
Carlos A. Casteñeda
Carlos A. Casteñeda
Amifostine
Medicine
Toxicity
Internal medicine
Gastroenterology
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering long-term survival.
2012
Hematology/Oncology and Stem Cell Therapy
Henry L. Gomez
C. Samanez
Frank Campana
Silvia P. Neciosup
Luis Vera
L. Casanova
J. León
Claudio Flores
Fernando Hurtado de Mendoza
Carlos A. Casteñeda
Joseph A. Pinto
Carlos S. Vallejos
Show All
Source
Cite
Save
Citations (1)
Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering long-term survival
2012
Hematology/Oncology and Stem Cell Therapy
Henry L. Gomez
C. Samanez
Frank Campana
Silvia P. Neciosup
Luis Vera
Luis Casanova
Jorge León
Claudio Flores
Fernando Hurtado de Mendoza
Carlos A. Casteñeda
Joseph A. Pinto
Carlos S. Vallejos
Show All
Source
Cite
Save
Citations (0)
1